Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 19, 2019 - Issue 4
Submit an article Journal homepage
623
Views
20
CrossRef citations to date
0
Altmetric
Original Research

Valuation of EQ-5D-5L health states: a comparison of seven Asian populations

Pei WangSchool of Public Health, Fudan University, Shanghai, China;Key Lab of Health Technology Assessment, National Health Commission of the People’s Republic of China (Fudan University), Shanghai, ChinaCorrespondence[email protected]
View further author information
,
Gordon G LiuNational School of Development, Peking University, Beijing, ChinaView further author information
,
Min-woo JoDepartment of Preventive Medicine, University of Ulsan College of Medicine, Seoul, KoreaView further author information
,
Frederick Dermawan PurbaMedical Psychology, Erasmus MC, Rotterdam, Netherlands;Faculty of Psychology, Universitas Padjadjaran, Jatinangor, IndonesiaView further author information
,
Zhihao YangMedical Psychology, Erasmus MC, Rotterdam, NetherlandsView further author information
,
Mihir GandhiBiostatistics, Singapore Clinical Research Institute, Singapore, Singapore;Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore, Singapore;Center for Child Health Research, University of Tampere, Tampere, FinlandView further author information
,
Juntana PattanaphesajHealth Intervention and Technology Assessment Program (HITAP), Bangkok, ThailandView further author information
,
Jeonghoon AhnDepartment of Health Convergence, Ewha Womans University, Seoul, KoreaView further author information
,
Eliza Lai-yi WongJC School of Public Health & Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, ChinaView further author information
,
Arsul A ShafieDiscipline of Social & Administrative Pharmacy, Universiti Sains Malaysia, Penang, MalaysiaView further author information
,
Jan JV BusschbachMedical Psychology, Erasmus MC, Rotterdam, NetherlandsView further author information
&
Nan LuoSaw Swee Hock School of Public Health, National University of Singapore, Singapore, SingaporeView further author information
 show all
Pages 445-451 | Received 04 Aug 2018, Accepted 05 Dec 2018, Published online: 13 Dec 2018

References

  • Doherty J, Kamae I, Lee KK, et al. What is next for pharmacoeconomics and outcomes research in Asia? Value Health. 2004;7:118–132.
  • Thorat T, Lin PJ, Neumann PJ. The state of cost-utility analyses in Asia: a systematic review. Value Health Reg Issues. 2015;6:7–13.
  • Liu GG, Hu SL, Wu JH, et al. China guidelines for pharmacoeconomic evaluations. China J Pharm Econ. 2010;3:5–43.
  • Kim CY. Health technology assessment in South Korea. Int J Technol Assess Health Care. 2009;25(1):219–223.
  • Tantivess S, Teerawattananon Y, Mills A. Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program. Pharmacoeconomics. 2009;27:931–945.
  • Pwee KH. Health technology assessment in Singapore. Int J Technol Assess Health Care. 2009;25(1):234–240.
  • Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35:1095–1108.
  • Feeny D, Furlong W, Boyle M, et al. Multi-attribute health status classification systems: health utilities index. Pharmacoeconomics. 1995;7:490–502.
  • Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271–292.
  • Luo N, Johnson JA, Shaw JW, et al. A comparison of EQ-5D index scores derived from the US and UK population-based scoring function. Med Decis Making. 2007;3:321–326.
  • Johnson JA, Luo N, Shaw JW, et al. Valuations of EQ-5D health states: are the United States and United Kingdom different? Med Care. 2005;43:221–228.
  • Baida X, Roset M, Herdman M, et al. A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making. 2001;21:7–16.
  • Norman R, Cronin P, Viney R, et al. International comparisons in valuing EQ-5D health states: a review and analysis. Value Health. 2009;12:1194–1200.
  • Wang P, Li MH, Liu GG, et al. Do Chinese have similar health-state preferences? A comparison of mainland Chinese and Singaporean Chinese. Eur J Health Econ. 2015;16:857–863.
  • Janssen MF, Bonsel GJ, Luo N. Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value sets from seven countries. Pharmacoeconomics. 2018;36:675–697.
  • Oppe M, Devlin NH, van Hout B. A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. Value Health. 2014;17:445–453.
  • Oppe M, Rand-Hendriksen K, Shah K, et al. EuroQol protocols for time trade-off valuation of health outcomes. Pharmacoeconomics. 2016;34:993–1004.
  • EuroQol Group. EQ-5D-5L user guide. Basic information on how to use the EQ-5D-5L instrument. [cited 2018 May 23]. Available from: http://www.euroqol.org/fileadmin/user_upload/Documenten/PDF/Folders_Flyers/UserGuide_EQ-5D-5L.pdf
  • Ramos-Goñi JM, Oppe M, Slaap B, et al. Quality control process for EQ-5D-5L valuation studies. Value Health. 2017;20:466–473.
  • Luo N, Liu GG, Li MH, et al. Estimating an EQ-5D-5L value set for China. Value Health. 2017;20:662–669.
  • Rand-Hendriksen K, Ramos-Goñi JM, Augestad LA, et al. Less is more: cross-validation testing of simplified nonlinear regression model specifications for EQ-5D-5L health state values. Value Health. 2017;20:945–952.
  • Luo N, Wang Y, How CH, et al. Interpretation and use of the 5-level EQ-5D response labels varied with survey language among Asians in Singapore. J Clin Epidemiol. 2015;68:1195–1204.
  • Lenert LA. The reliability and internal consistency of an Internet-capable computer program for measuring utilities. Qual Life Res. 2000;9:811–817.
  • Yang Z, van Busschbach J, Timman R, et al. Logical inconsistences in time trade-off valuation of EQ-5D-5L health states: whose fault is it? PLoS One. 2017;12:e01848883.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.